Literature DB >> 24682862

Association between the growth rate of renal cysts/angiomyolipomas and age in the patients with tuberous sclerosis complex.

Jeng-Dau Tsai1, Chang-Ching Wei, Shan-Ming Chen, Ko-Huang Lue, Ji-Nan Sheu.   

Abstract

PURPOSE: Renal manifestations of tuberous sclerosis complex (TSC) occur with a high frequency and a wide range of severity. The onset and complications of each affected organ depend on the age. This study aimed to investigate the associations between comorbidities, frequency, and size of cysts/angiomyolipomas of TSC and the patients in the different ages.
METHODS: We performed a systematic evaluation of patients with TSC at integrated clinics for TSC. The patients were diagnosed with TSC according to Roach's clinical diagnostic criteria. All the patients underwent a systematic evaluation with a medical history review, recording of cutaneous manifestations, magnetic resonance imaging of the brain, chest computed tomography scan, and cardiac echography. Each patient was routinely evaluated with renal magnetic resonance imaging.
RESULTS: Of the 57 patients with TSC, renal lesions or manifestations were observed in 38.5 % at preschool-age group (<6 years) that increased to 75.0, 85.7, and 100 % in school-age group (6-18 years), young adulthood group (18-30 years), and middle-aged group >30 years, respectively. Renal complications or interventions were found in 72.7 % of patients >30 years. There was a strongly positive association between the size of renal lesions and age (p < 0.001). Comorbidities of TSC were significantly correlated with pulmonary lymphangiomyomatosis (p < 0.001) and seizure remission (p = 0.018).
CONCLUSIONS: The results indicate a positive association of progressively growing renal lesions in patients with TSC with increasing age. It is mandatory for clinicians that monitor the high-risk patients to minimize and prevent renal complications in the future.

Entities:  

Mesh:

Year:  2014        PMID: 24682862     DOI: 10.1007/s11255-014-0701-6

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  22 in total

1.  Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis.

Authors:  T Carsillo; A Astrinidis; E P Henske
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

Review 2.  The diverse clinical manifestations of tuberous sclerosis complex: a review.

Authors:  Tena Rosser; Ashok Panigrahy; William McClintock
Journal:  Semin Pediatr Neurol       Date:  2006-03       Impact factor: 1.636

Review 3.  The tuberous sclerosis complex.

Authors:  Ksenia A Orlova; Peter B Crino
Journal:  Ann N Y Acad Sci       Date:  2010-01       Impact factor: 5.691

4.  Tuberous sclerosis complex: diagnostic challenges, presenting symptoms, and commonly missed signs.

Authors:  Brigid A Staley; Emily A Vail; Elizabeth A Thiele
Journal:  Pediatrics       Date:  2010-12-20       Impact factor: 7.124

Review 5.  Aberrant cellular differentiation and migration in renal and pulmonary tuberous sclerosis complex.

Authors:  Aristotelis Astrinidis; Elizabeth Petri Henske
Journal:  J Child Neurol       Date:  2004-09       Impact factor: 1.987

Review 6.  [Guidelines for the management of tuberous sclerosis complex renal disease].

Authors:  O Rouvière; H Nivet; N Grenier; L Zini; E Lechevallier
Journal:  Prog Urol       Date:  2012-04-30       Impact factor: 0.915

7.  Renal lesion growth in children with tuberous sclerosis complex.

Authors:  D H Ewalt; E Sheffield; S P Sparagana; M R Delgado; E S Roach
Journal:  J Urol       Date:  1998-07       Impact factor: 7.450

8.  Prevalence of tuberous sclerosis complex in Taiwan: a national population-based study.

Authors:  Chien-Hui Hong; Thomas N Darling; Chih-Hung Lee
Journal:  Neuroepidemiology       Date:  2009-11-04       Impact factor: 3.282

9.  Angiomyolipomata: challenges, solutions, and future prospects based on over 100 cases treated.

Authors:  Prasanna Sooriakumaran; Philippa Gibbs; Geoffrey Coughlin; Virginia Attard; Frances Elmslie; Christopher Kingswood; Jeremy Taylor; Cathy Corbishley; Uday Patel; Christopher Anderson
Journal:  BJU Int       Date:  2009-06-02       Impact factor: 5.588

10.  mTOR Inhibitors in Tuberous Sclerosis Complex.

Authors:  Paolo Curatolo; Romina Moavero
Journal:  Curr Neuropharmacol       Date:  2012-12       Impact factor: 7.363

View more
  6 in total

Review 1.  Tuberous sclerosis complex: the past and the future.

Authors:  Liesbeth De Waele; Lieven Lagae; Djalila Mekahli
Journal:  Pediatr Nephrol       Date:  2014-12-23       Impact factor: 3.714

2.  Congenital focal lymphedema as a diagnostic clue to tuberous sclerosis complex: report of two cases diagnosed by ultrasound.

Authors:  Sodai Hoshiai; Eiji Oguma; Yumiko Sato; Takahiro Konishi; Manabu Minami
Journal:  Skeletal Radiol       Date:  2015-01-24       Impact factor: 2.199

3.  Association between the growth rate of subependymal giant cell astrocytoma and age in patients with tuberous sclerosis complex.

Authors:  Jeng-Dau Tsai; Chang-Ching Wei; Teng-Fu Tsao; Yu-Ping Hsiao; Henry J Tsai; Sheng-Hui Yang; Min-Ling Tsai; Ji-Nan Sheu
Journal:  Childs Nerv Syst       Date:  2015-11-09       Impact factor: 1.475

4.  Angiomyolipoma of the Glabellar Region.

Authors:  Hyo Joong Kim; Chan Min Chung; Jae Yeon Park; Sung Gyun Jung
Journal:  Arch Craniofac Surg       Date:  2017-09-26

5.  The effect of everolimus on renal angiomyolipoma in pediatric patients with tuberous sclerosis being treated for subependymal giant cell astrocytoma.

Authors:  John J Bissler; David N Franz; Michael D Frost; Elena Belousova; E Martina Bebin; Steven Sparagana; Noah Berkowitz; Antonia Ridolfi; J Christopher Kingswood
Journal:  Pediatr Nephrol       Date:  2017-10-09       Impact factor: 3.714

6.  Clinical management of tuberous sclerosis complex over the lifetime of a patient.

Authors:  Michael Frost; John Hulbert
Journal:  Pediatric Health Med Ther       Date:  2015-08-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.